How to Respond to FDA Form 483s and Warning Letters
July 10, 2017
Many medical device manufacturers receive FDA warning letters due to lack of preparation for the FDA inspection and/or an inadequate response to an FDA Form 483.
The manner in which manufacturers respond to the 483 is critical in mitigating potential compliance risks and preventing the issuance of a warning letter. This article by NSF’s Kristen Grumet, published in Medical Design and Outsourcing, explains six key steps manufacturers can take when issued the FDA Form 483.
How NSF Can Help You
Get in touch to find out how we can help you and your business thrive.
What’s New with NSF
NSF Achieves European Accreditation for Drinking Water Product Certification Ahead of 2027 EU Deadline
July 22, 2026The ISO/IEC 17065 accreditation from BELAC complements NSF’s testing capacity, enabling end-to-end support for EU Drinking Water Directive (DWD) readiness ahead of the January 2027 deadline.
Meet NSF at Fruit Attraction
July 15, 2026NSF is excited to be exhibiting at Fruit Attraction, a leading international trade fair for the fruit and vegetable sector.
NSF Awards World-First Community Catch Certification to Orkney Crab Fishery
July 13, 2026Milestone certification sets a new benchmark for small-scale fishery sustainability and social responsibility.
NSF To Offer In-Person GMP and Regulatory Compliance Courses at SupplySide Global 2026
July 13, 2026NSF is offering a comprehensive GMP and regulatory compliance training program of classroom-based courses for dietary supplement industry professionals at SupplySide Global 2026.